Charles River Laboratories International Inc (CRL) Price Prediction & ForecastCRLCharles River Laboratories International Inc

Alphio's CRL stock price prediction model matches the current Charles River Laboratories International Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $280.14 (-0.78%). The 1-week path is $286.83 (+1.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Charles River Laboratories is a good buy right now due to its recent earnings performance and positive analyst upgrades. The current price is $291.5, which is below the analyst price target of $300, suggesting a potential upside of about 3%. Additionally, the company reported a strong Q2 EPS of $3.02, exceeding expectations and reflecting solid revenue growth of $1 billion, which is above the consensus estimate of $977.2 million. The main risk is the negative net income reported in recent quarters, with a net loss of $14.8 million in Q1 2026 and $1.48 million in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.

Charles River Laboratories International Inc (CRL) last closed at $282.34, losing -2.05%. These facts feed the 1-day and 1-week CRL price prediction above.